FGF SIGNALING AND PITUITARY TUMORIGENESIS
FGF 信号传导和垂体肿瘤发生
基本信息
- 批准号:6177554
- 负责人:
- 金额:$ 18.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-14 至 2002-06-30
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction cell growth regulation fibroblast growth factor gel mobility shift assay gene expression genetic promoter element growth factor receptors mitogen activated protein kinase molecular oncology neoplasm /cancer genetics neoplastic transformation phospholipase C phosphorylation pituitary neoplasms polymerase chain reaction prolactin protein kinase C receptor expression southern blotting tissue /cell culture transcription factor transfection western blottings
项目摘要
DESCRIPTION (Adapted from the applicant's abstract): In preliminary
studies done during his fellowship, the Dr. Bradford demonstrated a role
for FGF in regulation of the prolactin (PRL) promoter in GH4 pituitary
cells. These preliminary studies indicate that FGF-2 and FFG-4 activate
PRL promoter activity in a Ras and Raf independent manner, but involve MAP
kinase and members of the Ets family of transcription factors. This
regulation is specific and not observed for the growth hormone promoter in
the same cells. Preliminary studies are also presented to suggest that
this pathway is protein kinase C (PKC) dependent through the use of
inhibitors and down-regulation of the enzyme. Based on these preliminary
data, four specific aims are described: To map precisely the FGF response
elements in the PRL promoter, the investigator will use a combination of
conventional techniques. These will include mutagenesis with functional
analysis of the PRL promoter using a luciferase assay, production of
heterologous FRE promoter constructs which can be inserted upstream of a
minimal viral promoter, insertion of PRL promoter element in the GH
promoter which is normally not FGF responsive, and analysis of the nuclear
factors binding to the FRE by both electrophoretic mobility shift assay
and southwestern analysis.
Analysis of FGF receptors and their responses in GH4 pituitary cells. FGF
receptor expression will be determined by RTPCR. Receptor activation in
tyrosine phosphorylation will be characterized, as will the mitogenic
response to FGF 2 and FGF 4. The investigator will also determine whether
there are changes in synthesis and secretion of prolactin in response to
FGF treatment.
Attempts will be made to identify and characterize the cytoplasmic
components of the FGF signaling pathway. Here the investigator will focus
on novel, non-Ras components which might account for the preliminary data.
He will specifically investigate the possibility that B-Raf and Rap I are
involve as well as phospholipase C and protein kinase C. Several other
pathways will also be tested for their participation.
Finally, the investigator will attempt to identify and characterize
nuclear components of the FGF signal transduction pathway with a focus on
the Ets transcription factors. These will be done through a series of
transfections with dominant negative Ets and other potential interacting
factors, through studies of the roles of GHF-1 and GHF-2 in the process
and functional studies of the potential role of Jun kinase, nuclear MAP
kinase and FGF induced phosphorylation of Ets factors.
描述(改编自申请人的摘要):初步
布拉德福德博士在奖学金中进行的研究表现出了角色
用于FGF在GH4垂体中催乳素(PRL)启动子的调节中
细胞。这些初步研究表明FGF-2和FFG-4激活
PRL启动子活动以RAS和RAF独立方式,但涉及MAP
激酶和ETS转录因子家族的成员。这
调节是特定的,在生长激素启动子中未观察到
相同的细胞。还提出了初步研究,以表明
该途径是蛋白质激酶C(PKC)依赖于使用
酶的抑制剂和下调酶。基于这些初步
数据,描述了四个具体目的:精确映射FGF响应
PRL启动子中的元素,研究人员将使用
传统技术。这些将包括具有功能性的诱变
使用荧光素酶测定法分析PRL启动子,生产
异源FRE启动子构建体,可以插入
最小病毒启动子,在GH中插入PRL启动子元件
通常不是FGF响应的启动子,核分析
两种电泳迁移率分析的因素与FRE结合
和西南分析。
FGF受体及其在GH4垂体细胞中的反应分析。 FGF
受体表达将由RTPCR确定。受体激活
酪氨酸磷酸化将被表征,有丝分裂也将
对FGF 2和FGF 4的响应。研究人员还将确定是否是否
催乳素的合成和分泌发生了变化
FGF治疗。
将尝试识别和表征细胞质
FGF信号通路的组件。在这里,调查员将集中精力
在新颖的非RAS组件上,可能解释了初步数据。
他将特别研究B-Raf和Rap I是
涉及以及磷脂酶C和蛋白激酶C.其他几个
途径还将进行参与测试。
最后,调查人员将尝试识别和表征
FGF信号转导途径的核成分,重点
ETS转录因子。这些将通过一系列
具有主要负ET和其他潜在相互作用的转染
通过研究GHF-1和GHF-2在此过程中的作用的因素
以及关于Jun激酶核图的潜在作用的功能研究
激酶和FGF诱导ETS因子的磷酸化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW P BRADFORD其他文献
ANDREW P BRADFORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW P BRADFORD', 18)}}的其他基金
THE ROLE OF PROTEIN KINASE C IN ENDOMETRIAL CANCER
蛋白激酶 C 在子宫内膜癌中的作用
- 批准号:
7046120 - 财政年份:2004
- 资助金额:
$ 18.75万 - 项目类别:
THE ROLE OF PROTEIN KINASE C IN ENDOMETRIAL CANCER
蛋白激酶 C 在子宫内膜癌中的作用
- 批准号:
6871315 - 财政年份:2004
- 资助金额:
$ 18.75万 - 项目类别:
THE ROLE OF PROTEIN KINASE C IN ENDOMETRIAL CANCER
蛋白激酶 C 在子宫内膜癌中的作用
- 批准号:
7362454 - 财政年份:2004
- 资助金额:
$ 18.75万 - 项目类别:
THE ROLE OF PROTEIN KINASE C IN ENDOMETRIAL CANCER
蛋白激酶 C 在子宫内膜癌中的作用
- 批准号:
7225981 - 财政年份:2004
- 资助金额:
$ 18.75万 - 项目类别:
THE ROLE OF PROTEIN KINASE C IN ENDOMETRIAL CANCER
蛋白激酶 C 在子宫内膜癌中的作用
- 批准号:
6712616 - 财政年份:2004
- 资助金额:
$ 18.75万 - 项目类别:
相似国自然基金
NudC在细胞初级纤毛生长调节中的作用及分子机制研究
- 批准号:31471259
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
溶血磷脂酸在心梗后心肌重塑中作用及受体调节信号研究
- 批准号:30170374
- 批准年份:2001
- 资助金额:18.0 万元
- 项目类别:面上项目
中枢神经生长调节的细胞和分子基础
- 批准号:39930090
- 批准年份:1999
- 资助金额:100.0 万元
- 项目类别:重点项目
相似海外基金
Characterization of the Regulation and Gene Targets of TBX2 in Rhabdomyosarcoma
横纹肌肉瘤中 TBX2 的调控和基因靶点的表征
- 批准号:
10731025 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Metabolic regulation of healthy aging by diet, mTOR signaling, and skeletal muscle
通过饮食、mTOR 信号传导和骨骼肌对健康衰老的代谢调节
- 批准号:
10730054 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Role of alveolar fibroblasts in extracellular matrix organization and alveolar type 1 cell differentiation
肺泡成纤维细胞在细胞外基质组织和肺泡1型细胞分化中的作用
- 批准号:
10731854 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
FGF21 as a mediator of RPE mitochondrial dysfunction
FGF21 作为 RPE 线粒体功能障碍的介质
- 批准号:
10586472 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD
阻断线粒体 Mg2 通道 Mrs2 在肥胖和 NAFLD 中的机制和治疗潜力
- 批准号:
10679847 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别: